OSR Health, Inc.(OSRH)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $3.5M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
OSRH Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for OSR Health, Inc. (OSRH), a Healthcare sector company. OSRH is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $3.5m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), OSR Health, Inc. reports quarterly revenue of $315.7K, net income of $-1.0M. Top institutional holders of OSRH by reported 13-F value include VANGUARD FIDUCIARY, CITADEL ADVISORS, JANE STREET GROUP, based on the most recent SEC filings. OSRH trades on the Nasdaq exchange and files with the SEC under CIK 1840425. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OSRH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OSR Health, Inc. directly from SEC EDGAR.
Revenue
Q2 2026
$315.7K
Net Income
Q2 2026
$-1.0M
ROIC
Q2 2026
-9.5%
D/E Ratio
Q2 2026
0.02
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-17.7% YoYNet Income
Operating Income
-56.8% YoYEPS (Diluted)
-50.3% YoYTotal Assets
-2.3% YoYTotal Debt
+1.1% YoYOp. Cash Flow
-134.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.9M -17.7% | $3.5M | — | — | — | — |
| Net Income | — | $-2.4M -697.1% | $403.8K +1241.0% | $-35.4K -969.8% | $-3.3K | — |
| Operating Income | $-18.3M -56.8% | $-11.7M -538.7% | $-1.8M -5073.2% | $-35.4K -969.8% | $-3.3K | — |
| EPS (Diluted) | $-0.80 -50.3% | $-0.53 -9603.6% | $0.01 +609.1% | $-0.00 | — | — |
| Total Assets | $171.2M -2.3% | $175.2M +378.4% | $36.6M +2887.9% | $1.2M +73.9% | $705.1K | — |
| Total Debt | $2.3M +1.1% | $2.3M +14.0% | $2.0M +77.0% | $1.1M | — | — |
| Operating Cash Flow | $-4.3M -134.0% | $-1.8M -125.9% | $-818.8K -19233.3% | $-4.2K -818.7% | $-461.00 | — |
Get alerted when OSRH's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for OSR Health, Inc. including:
Top Institutional Holders of OSRH
VANGUARD FIDUCIARY TRUST CO
$46.9K148,266 shCITADEL ADVISORS LLC
$40.4K127,810 shJANE STREET GROUP, LLC
$40.2K127,195 shGEODE CAPITAL MANAGEMENT, LLC
$31.8K100,458 shTWO SIGMA SECURITIES, LLC
$14.7K46,537 shVANGUARD CAPITAL MANAGEMENT LLC
$11.8K37,373 shXTX Topco Ltd
$10.2K32,380 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$5.8K18,282 shNORTHERN TRUST CORP
$3.5K10,906 shTower Research Capital LLC (TRC)
$2.1K6,587 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD FIDUCIARY TRUST CO | $46.9K | 148,266 |
| CITADEL ADVISORS LLC | $40.4K | 127,810 |
| JANE STREET GROUP, LLC | $40.2K | 127,195 |
| GEODE CAPITAL MANAGEMENT, LLC | $31.8K | 100,458 |
| TWO SIGMA SECURITIES, LLC | $14.7K | 46,537 |
| VANGUARD CAPITAL MANAGEMENT LLC | $11.8K | 37,373 |
| XTX Topco Ltd | $10.2K | 32,380 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.8K | 18,282 |
| NORTHERN TRUST CORP | $3.5K | 10,906 |
| Tower Research Capital LLC (TRC) | $2.1K | 6,587 |
More Healthcare Companies
View all Healthcare →Put OSRH on your watchlist
Track score changes the day OSR Health, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is OSRH a good stock to buy?
13F Pro's AI-powered analysis of OSR Health, Inc. (OSRH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OSRH are available on the OSRH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. OSRH is classified as a small company.
Which hedge funds own OSRH?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OSRH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of OSR Health, Inc.'s investment landscape.